nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A UK Civil Aviation Authority protocol to allow pilots with insulin-treated diabetes to fly commercial aircraft
|
Mitchell, Stuart J |
|
|
5 |
9 |
p. 677-679 |
artikel |
2 |
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
|
Birkeland, Kåre I |
|
|
5 |
9 |
p. 709-717 |
artikel |
3 |
Common measures of chronic kidney disease improve vascular risk prediction
|
Stack, Austin G |
|
|
5 |
9 |
p. 675-677 |
artikel |
4 |
Correction to Lancet Diabetes Endocrinol 2017; 5: 524–33
|
|
|
|
5 |
9 |
p. e6 |
artikel |
5 |
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial
|
Beck, Roy W |
|
|
5 |
9 |
p. 700-708 |
artikel |
6 |
Glucose-lowering drugs: balancing risks and benefits
|
The Lancet Diabetes & Endocrinology, |
|
|
5 |
9 |
p. 669 |
artikel |
7 |
Hyperinsulinaemic hypoglycaemia in children and adults
|
Shah, Pratik |
|
|
5 |
9 |
p. 729-742 |
artikel |
8 |
Issues with European guidelines for phenylketonuria
|
Burgard, Peter |
|
|
5 |
9 |
p. 681-683 |
artikel |
9 |
Issues with European guidelines for phenylketonuria – Authors' reply
|
van Spronsen, Francjan J |
|
|
5 |
9 |
p. 683-684 |
artikel |
10 |
Key European guidelines for the diagnosis and management of patients with phenylketonuria
|
van Spronsen, Francjan J |
|
|
5 |
9 |
p. 743-756 |
artikel |
11 |
Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
|
Matsushita, Kunihiro |
|
|
5 |
9 |
p. 718-728 |
artikel |
12 |
Meta-analysis of artificial pancreas trials: methodological considerations
|
Bekiari, Eleni |
|
|
5 |
9 |
p. 685 |
artikel |
13 |
Meta-analysis of artificial pancreas trials: methodological considerations – Authors' reply
|
Weisman, Alanna |
|
|
5 |
9 |
p. 685-686 |
artikel |
14 |
Nizar Albache: championing the cause of Syrian refugees with diabetes
|
Thorley, Jennifer |
|
|
5 |
9 |
p. 688 |
artikel |
15 |
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|
Williams, Tracy A |
|
|
5 |
9 |
p. 689-699 |
artikel |
16 |
Rating the blood pressure outcome after adrenalectomy for unilateral primary aldosteronism
|
Steichen, Olivier |
|
|
5 |
9 |
p. 670-671 |
artikel |
17 |
Research digest: more cardiovascular outcome trials in diabetes
|
Sattar, Naveed |
|
|
5 |
9 |
p. 687 |
artikel |
18 |
Sensor mightier than pump—the jury is still out
|
Hovorka, Roman |
|
|
5 |
9 |
p. 672-673 |
artikel |
19 |
SGLT2 inhibitors and amputations in the US FDA Adverse Event Reporting System
|
Fadini, Gian Paolo |
|
|
5 |
9 |
p. 680-681 |
artikel |
20 |
SGLT2 inhibitors in the real world: too good to be true?
|
Fitchett, David |
|
|
5 |
9 |
p. 673-675 |
artikel |